Streptococcal pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1399-1407

  Sriskandan, Shirance ^a   Moves, David ^a   Lee Buttery, K ^a   Krausz, Thomas ^a   Evans, Thomas J ^a   Polak, Julia ^a   Cohen, Jonathan ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; EXOTOXIN; INTERLEUKIN 6; NEUTRALIZING ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FASCIITIS; MALE; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SURVIVAL;

EID: 0029827703     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1399     Document Type: Article

References (13)

1. Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 1993;269:390-1.
2. Talkington DF, Schwartz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993;61:3369-74.
3. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1 -7.
4. Kapur V, Topouzis S, Majesky MW, et al. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 1993; 15:327-46.
5. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases; clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991:88:2668-72.
6. Braun MA, Gerlach D, Hartwig UF, et al. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J Immunol 1993; 150:2457-66.
7. Watanabe-Ohnishi R, Low DE, McGreer A, et al. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J Infect Dis 1995;171:74-84.
8. Schlievert PM. Role of superantigens in disease. J Infect Dis 1993; 167: 997-1002.
9. Selbie FR, Simon RD. Virulence to mice of Staphyhcoccus pyogenes: its measurement and its relation to certain in vitro properties. Br J Exp Pathol 1952;33:315-26.
10. Shu S, Ju G, Fan L. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988;85:16971.
11. Weeks CR, Ferretti JJ. Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from the Streptococcus pyogenes bacteriophage T12. Infect Immun 1986; 52:144-50.
12. Altman DG. Practical statistics for medical research. In: Practical statistics for medical research. London: Chapman & Hall, 1991:179-395.
13. Martin RA, Silva AT, Cohen J. Effect of anti-TNF-α treatment in an antibiotic treated murine model of infection due to Streptococcus pyogenes. FEMS Microbiol Lett 1992;79:313-22.